1. Goldie JH. Drug resistance in cancer: a perspective. Cancer Metastasis Rev 2001; 20:63–68.
2. McCarty MF, Liu W, Fan F, et al. Promises and pitfalls of anti-angiogenic therapy in clinical trials. Trends Mol Med 2003; 9:53–58.
3. Miller BE, Miller FR, Heppner GH. Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophospamide and methotrexate. Cancer Res 1981; 41:4378–4381.
4. Miller BE, Miller FR, Heppner GH. Therapeutic perturbation of the tumor ecosystem in reconstructed heterogeneous mouse mammary tumors. Cancer Res 1989; 49:3747–3753.
5. Heppner GH, Miller BE. Therapeutic implications of tumor heterogeneity. Semin Oncol 1989; 16:91–105.